MENU
IKNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ikena Oncology (IKNA) Ownership - Who owns Ikena Oncology?
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more
Profile
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
57.91M
P/E Ratio
N/A
Total Cash
124.39M
Projected Growth
N/A
Total Debt
7.52M
Revenue
N/A
Risk (Beta)
0.53
Dividend Yield
N/A
Total Cash/Share
2.58
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IKNA
Capitalization
57.9M
P/E Ratio
N/A
Risk (Beta)
0.53
Dividend Yield
N/A
Total Cash
124M
Total Cash/Share
2.58
Total Debt
7.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
126M
P/B Ratio
0.46
Cash Flow
N/A
Earnings
-1.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
48K
Current Ratio
11.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-54.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.52
Shares Held By Institutions
42.8M
Shares Outstanding - Current
48.3M
Total Liabilities
15.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-23.780
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com